L
Li Wei
Researcher at Wuhan University
Publications - 7
Citations - 94
Li Wei is an academic researcher from Wuhan University. The author has contributed to research in topics: Cardioprotection & Oxidative stress. The author has an hindex of 3, co-authored 7 publications receiving 32 citations.
Papers
More filters
Journal ArticleDOI
Andrographolide Protects Against Adverse Cardiac Remodeling After Myocardial Infarction through Enhancing Nrf2 Signaling Pathway.
Saiyang Xie,Wei Deng,Jiao-Jiao Chen,Qing-Qing Wu,Hongjian Li,Juan Wang,Li Wei,Chen Liu,Mingxia Duan,Zhulan Cai,Qingwen Xie,Tongtong Hu,Xiao-Feng Zeng,Qi-Zhu Tang +13 more
TL;DR: It is suggested that Andr alleviates adverse cardiac remodeling following myocardial infarction through enhancing Nrf2 signaling pathway.
Journal ArticleDOI
Inhibition of 5-lipoxygenase is associated with downregulation of the leukotriene B4 receptor 1/ Interleukin-12p35 pathway and ameliorates sepsis-induced myocardial injury.
Saiyang Xie,Xiping Qi,Qing-Qing Wu,Li Wei,Min Zhang,Yun Xing,Wenke Shi,Si Chen,Xiao-Feng Zeng,Sha-Sha Wang,Haipeng Guo,Wei Deng +11 more
TL;DR: In this article, 5-Lox deficiency offered protection against myocardial injury in a mouse model of sepsis and attenuated septic-mediated inflammation, oxidative stress and apoptosis in the mouse heart.
Journal ArticleDOI
Attenuation of cardiac remodeling by indole-3-carbinol in mice is associated with improved energy metabolism
Journal ArticleDOI
Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway.
TL;DR: Levosimendan may protect against DOX-induced cardiotoxicity via modulation of the PTEN/Akt signaling pathway and reduce the cardiac dysfunction and attenuated the myocardial apoptosis induced by DOX in vivo and in vitro.
Journal ArticleDOI
Effects of Hesperetin on Platelet-Derived Growth factor-BB-induced Pulmonary Artery Smooth Muscle Cell Proliferation
TL;DR: The results suggested that hesperetin may inhibit PDGFa‑BB‑induced PASMC proliferation via the AKT/GSK3β signaling pathway, and that it may possess therapeutic potential for the treatment of pulmonary vascular remodeling diseases.